MJFF Grant Will Help Inflazome Develop Brain-imaging Probe for Parkinson’s Research
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has granted more than $1 million to Inflazome to fund…
Articles by José Lopes, PhD
Review Study Provides Update on Treatments for Parkinson’s Non-motor Symptoms
Although there are now more treatment options available for non-motor symptoms in Parkinson’s disease, a lack of evidence on…
Motor Dysfunction Among the Predictive Markers of Parkinson’s for People with Sleep Disorder, Study Reports
Mild cognitive impairment, motor and olfactory deficits, and erectile dysfunction are among the markers able to predict the development of…
Hydrotherapy Improves Balance, Mobility in Parkinson’s Patients, Study Reports
Hydrotherapy may provide significant balance and mobility benefits in patients with Parkinson’s disease compared to medication and land-based exercises, according…
Proper Nutrition May Prevent More Severe Motor Problems in Parkinson’s, Study Suggests
Maintaining good nutritional status may protect Parkinson’s patients from greater motor impairments associated with weight loss, according to new research.
Manganese Exposure May Be Linked to Parkinson’s Development, Study Suggests
Exposure to the metal manganese may lead to the development of Parkinson’s disease by promoting the release from nerve…
Leukemia Treatment Tasigna Improves Brain Dopamine Use In Parkinson’s Patients, Trial Finds
Treatment with a single dose of the leukemia therapy Tasigna (nilotinib) improves the brain’s ability to use dopamine in…
Synchronizing Finger Taps to Regular Beats Improves Gait of Parkinson’s Patients, Study Suggests
Parkinson’s disease patients improved their gait after undergoing training in which they tapped their fingers in synchrony to regular beats…
AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial
One-time treatment with the gene therapy candidate AXO-Lenti-PD led to improved motor function and was well-tolerated after three months…
Seelos to Test Potential Parkinson’s Treatment Targeting Alpha-synuclein Clumps
Seelos Therapeutics has acquired an exclusive license to further develop a treatment approach called SLS-007 for Parkinson’s disease which is…